FDA Registers AstraZeneca’s COVID-19 Vaccine
08 January 2021 11:56
24 The secretary-general of the Food and Drug Administration registered the COVID-19 vaccine that AstraZeneca Co developed, for the emergency use of 50,000 doses to cope with the disease spread crisis in the country.
